{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:07:39Z","timestamp":1788815259471,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001721","name":"Rijksuniversiteit Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005075","name":"Universitair Medisch Centrum Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202108310110"],"award-info":[{"award-number":["202108310110"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118367","type":"journal-article","created":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T11:34:11Z","timestamp":1786880051000},"page":"118367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Upadacitinib effectively suppresses IL13RA2 expression in primary human intestinal fibroblasts derived from Crohn\u2019s disease tissue"],"prefix":"10.1016","volume":"253","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4881-4094","authenticated-orcid":false,"given":"Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke","family":"Sinnema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Teunis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinse","family":"Weersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Bigaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas Nico","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2026.118367_b0005","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4251\/wjgo.v14.i3.547","article-title":"Inflammatory bowel disease-related colorectal cancer: past, present and future perspectives","volume":"14","author":"Majumder","year":"2022","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.bcp.2026.118367_b0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejim.2021.08.010","article-title":"Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: current practice and future perspectives","volume":"93","author":"Wijnands","year":"2021","journal-title":"Eur. J. Intern. Med."},{"issue":"10114","key":"10.1016\/j.bcp.2026.118367_b0015","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bcp.2026.118367_b0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065186","article-title":"Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.bcp.2026.118367_b0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: pathogenesis","volume":"20","author":"Zhang","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118367_b0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/flgastro-2023-102400","article-title":"JAK inhibitors for inflammatory bowel disease: recent advances","volume":"15","author":"Honap","year":"2024","journal-title":"Frontline Gastroenterology"},{"key":"10.1016\/j.bcp.2026.118367_b0035","article-title":"JAK inhibitors: a new dawn for oral therapies in inflammatory bowel diseases","volume":"10","author":"Herrera-deGuise","year":"2023","journal-title":"Front. Med. (Lausanne)"},{"issue":"11","key":"10.1016\/j.bcp.2026.118367_b0040","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/bph.13476","article-title":"Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1) and receptor-5 (S1P5) agonist with autoimmune disease-modifying activity","volume":"173","author":"Scott","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118367_b0045","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ecco-jcc\/jjz195","article-title":"Predictors of primary response to biologic treatment [anti-TNF, vedolizumab, and ustekinumab] in patients with inflammatory bowel disease: from basic science to clinical practice","volume":"14","author":"Gisbert","year":"2020","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bcp.2026.118367_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103329","article-title":"Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: current and novel biomarkers","volume":"66","author":"Cui","year":"2021","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.bcp.2026.118367_b0055","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1136\/gut.2009.178665","article-title":"Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis","volume":"58","author":"Arijs","year":"2009","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.bcp.2026.118367_b0060","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/apt.15126","article-title":"Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's disease","volume":"49","author":"Verstockt","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2026.118367_b0065","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ebiom.2019.01.027","article-title":"Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease","volume":"40","author":"Verstockt","year":"2019","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.bcp.2026.118367_b0070","article-title":"A multi-mRNA prognostic signature for anti-TNF\u03b1 therapy response in patients with inflammatory bowel disease","volume":"11","author":"Sakaram","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"11","key":"10.1016\/j.bcp.2026.118367_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21154","article-title":"Prediction of anti-TNF therapy failure in ulcerative colitis patients by ensemble machine learning: a prospective study","volume":"9","author":"Derakhshan Nazari","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.bcp.2026.118367_b0080","article-title":"Effects of epithelial IL-13R\u03b12 expression in inflammatory bowel disease","volume":"9\u20132018","author":"Verstockt","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118367_b0085","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41385-019-0189-6","article-title":"Anti-IL-13R\u03b12 therapy promotes recovery in a murine model of inflammatory bowel disease","volume":"12","author":"Karmele","year":"2019","journal-title":"Mucosal Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118367_b0090","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","article-title":"Intra- and inter-cellular rewiring of the human colon during ulcerative colitis","volume":"178","author":"Smillie","year":"2019","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bcp.2026.118367_b0095","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41577-021-00540-z","article-title":"Fibroblasts as immune regulators in infection, inflammation and cancer","volume":"21","author":"Davidson","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118367_b0100","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf076","article-title":"Differential effects of tofacitinib on macrophage activation contribute to lack of response in ulcerative colitis patients","volume":"19","author":"Mel\u00f3n-Ardanaz","year":"2025","journal-title":"J. Crohn's Colitis"},{"issue":"1","key":"10.1016\/j.bcp.2026.118367_b0105","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12876-019-0938-8","article-title":"Correction to: the 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1","volume":"19","author":"Imhann","year":"2019","journal-title":"BMC Gastroenterol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118367_b0110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gutjnl-2016-312135","article-title":"Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease","volume":"67","author":"Imhann","year":"2018","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bcp.2026.118367_b0115","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41467-024-45855-2","article-title":"Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease","volume":"15","author":"Hu","year":"2024","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.bcp.2026.118367_b0120","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1158\/1078-0432.CCR-13-0694","article-title":"Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature","volume":"19","author":"Herrera","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118367_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030775","article-title":"Pirfenidone inhibits cell proliferation and collagen I production of primary human intestinal fibroblasts","volume":"9","author":"Cui","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.bcp.2026.118367_b0130","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/art.41958","article-title":"Effect of JAK inhibition on the induction of proinflammatory HLA-DR+CD90+ rheumatoid arthritis synovial fibroblasts by interferon-\u03b3","volume":"74","author":"Zhao","year":"2022","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118367_b0135","doi-asserted-by":"crossref","first-page":"L698","DOI":"10.1152\/ajplung.00428.2021","article-title":"Noncanonical JAK1\/STAT3 interactions with TGF-\u03b2 modulate myofibroblast transdifferentiation and fibrosis","volume":"323","author":"Wang","year":"2022","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"22","key":"10.1016\/j.bcp.2026.118367_b0140","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1038\/sj.onc.1206352","article-title":"Functional characterization of IL-13 receptor alpha2 gene promoter: a critical role of the transcription factor STAT6 for regulated expression","volume":"22","author":"David","year":"2003","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.bcp.2026.118367_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208922","article-title":"Quantitative comparison of the neutralizing capacity, immunogenicity and cross-reactivity of anti-TNF-\u03b1 biologicals and an infliximab-biosimilar","volume":"13","author":"Buurman","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.118367_b0150","article-title":"Increased stromal PFKFB3-mediated glycolysis in inflammatory bowel disease contributes to intestinal inflammation","volume":"13\u20132022","author":"Zhou","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118367_b0155","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3390\/ph15050622","article-title":"Tofacitinib may inhibit myofibroblast differentiation from rheumatoid-fibroblast-like synoviocytes induced by TGF-\u03b2 and IL-6","volume":"15","author":"Ruscitti","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.bcp.2026.118367_b0160","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.157091","article-title":"IL-13RA2 downregulation in fibroblasts promotes keloid fibrosis via JAK\/STAT6 activation","volume":"8","author":"Chao","year":"2023","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.bcp.2026.118367_b0165","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1038\/s41467-021-26099-w","article-title":"Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis","volume":"12","author":"Kuzumi","year":"2021","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.bcp.2026.118367_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23168900","article-title":"IL11 stimulates IL33 expression and proinflammatory fibroblast activation across tissues","volume":"23","author":"Widjaja","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118367_b0175","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s13287-023-03493-3","article-title":"Growth differentiation factor 7 autocrine signaling promotes hepatic progenitor cell expansion in liver fibrosis","volume":"14","author":"Kong","year":"2023","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"10.1016\/j.bcp.2026.118367_b0180","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ibd.20088","article-title":"Decreased P-glycoprotein (P-gp\/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels","volume":"13","author":"Blokzijl","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"issue":"2","key":"10.1016\/j.bcp.2026.118367_b0185","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202001564RR","article-title":"Collagen release by human hepatic stellate cells requires vitamin C and is efficiently blocked by hydroxylase inhibition","volume":"35","author":"Smith-Cortinez","year":"2021","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.bcp.2026.118367_b0190","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/hmg\/ddz283","article-title":"Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels","volume":"29","author":"Saeed","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcp.2026.118367_b0195","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.3389\/fimmu.2018.02983","article-title":"Effects of epithelial IL-13R\u03b12 expression in inflammatory bowel disease","volume":"9","author":"Verstockt","year":"2018","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118367_b0200","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/labinvest.3780336","article-title":"Expression of interleukin 13 receptor in glioma and renal cell carcinoma: IL13Ralpha2 as a decoy receptor for IL13","volume":"81","author":"Bernard","year":"2001","journal-title":"Lab. Invest."},{"issue":"9","key":"10.1016\/j.bcp.2026.118367_b0205","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood.V97.9.2673","article-title":"The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway","volume":"97","author":"Kawakami","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bcp.2026.118367_b0210","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nm1332","article-title":"IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis","volume":"12","author":"Fichtner-Feigl","year":"2006","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.bcp.2026.118367_b0215","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/j.gastro.2023.07.014","article-title":"Stricturing Crohn\u2019s disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactions","volume":"165","author":"Mukherjee","year":"2023","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bcp.2026.118367_b0220","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/s41598-020-57972-1","article-title":"Transcriptional regulation of the IL-13R\u03b12 gene in human lung fibroblasts","volume":"10","author":"Penke","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2026.118367_b0225","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cyto.2003.08.006","article-title":"The negative-feedback regulation of the IL-13 signal by the IL-13 receptor alpha2 chain in bronchial epithelial cells","volume":"24","author":"Yasunaga","year":"2003","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.bcp.2026.118367_b0230","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s41927-018-0031-x","article-title":"In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)","volume":"2","author":"Parmentier","year":"2018","journal-title":"BMC Rheumatology"},{"issue":"1","key":"10.1016\/j.bcp.2026.118367_b0235","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/imr.13230","article-title":"Engineering the IL-4\/IL-13 axis for targeted immune modulation","volume":"320","author":"Bernstein","year":"2023","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.bcp.2026.118367_b0240","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.jaci.2023.07.021","article-title":"IL-13-induced STAT3-dependent signaling networks regulate esophageal epithelial proliferation in eosinophilic esophagitis","volume":"152","author":"Marella","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"20","key":"10.1016\/j.bcp.2026.118367_b0245","doi-asserted-by":"crossref","first-page":"10416","DOI":"10.1128\/JVI.01525-15","article-title":"Constitutive activation of interleukin-13\/STAT6 contributes to kaposi's sarcoma-associated herpesvirus-related primary effusion lymphoma cell proliferation and survival","volume":"89","author":"Wang","year":"2015","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118367_b0250","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41598-020-57815-z","article-title":"Unique IL-13R\u03b12\/STAT3 mediated IL-13 regulation detected in lung conventional dendritic cells, 24\u2009h post viral vector vaccination","volume":"10","author":"Roy","year":"2020","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.bcp.2026.118367_b0255","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1038\/sj.onc.1206352","article-title":"Functional characterization of IL-13 receptor \u03b12 gene promoter: a critical role of the transcription factor STAT6 for regulated expression","volume":"22","author":"David","year":"2003","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bcp.2026.118367_b0260","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000960","article-title":"Combining cytokine-related biomarkers to better define tumor necrosis factor-\u03b1 antagonist response in inflammatory bowel disease: an observational cohort study","volume":"17","author":"Rooney","year":"2026","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"21","key":"10.1016\/j.bcp.2026.118367_b0265","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1056\/NEJMoa2212728","article-title":"Upadacitinib induction and maintenance therapy for crohn\u2019s disease","volume":"388","author":"Loftus","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.bcp.2026.118367_b0270","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1053\/j.gastro.2020.02.030","article-title":"Efficacy of upadacitinib in a randomized trial of patients with active ulcerative colitis","volume":"158","author":"Sandborn","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2026.118367_b0275","article-title":"Systematic review with meta-analysis: safety and effectiveness of combining biologics and small molecules in inflammatory bowel diseases","author":"Anderson","year":"2025","journal-title":"Inflamm. Bowel Dis."},{"issue":"10","key":"10.1016\/j.bcp.2026.118367_b0280","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/apt.70298","article-title":"Research communication: combination therapy of upadacitinib with infliximab, risankizumab, ustekinumab or vedolizumab for refractory crohn's disease: a descriptive case series","volume":"62","author":"Dalal","year":"2025","journal-title":"Aliment. Pharmacol. Ther."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226007069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226007069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:13:04Z","timestamp":1788811984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226007069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":56,"alternative-id":["S0006295226007069"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118367","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upadacitinib effectively suppresses IL13RA2 expression in primary human intestinal fibroblasts derived from Crohn\u2019s disease tissue","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118367"}}